Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/CGS-20625> ?p ?o }
Showing triples 1 to 74 of
74
with 100 triples per page.
- CGS-20625 abstract "CGS-20625 is an anxiolytic drug used in scientific research. It has similar effects to, and binds to the same target as benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.CGS-20625 produces anxiolytic and anticonvulsant effects, but with no sedative effects even at high doses, and no significant muscle relaxant effects. It is orally active in humans, but with relatively low bioavailability.".
- CGS-20625 atcPrefix "none".
- CGS-20625 bioavailability "41.0".
- CGS-20625 casNumber "111205-55-1".
- CGS-20625 iupacName "5,6,7,8,9,10-hexahydro-2-(4-methoxyphenyl)-cyclohepta[b]pyrazolo[3,4-d]pyridin-3(2H)-one".
- CGS-20625 pubchem "163844".
- CGS-20625 thumbnail CGS-20625.svg?width=300.
- CGS-20625 wikiPageID "16190529".
- CGS-20625 wikiPageLength "3969".
- CGS-20625 wikiPageOutDegree "7".
- CGS-20625 wikiPageRevisionID "659857158".
- CGS-20625 wikiPageWikiLink Anxiolytic.
- CGS-20625 wikiPageWikiLink Benzodiazepine.
- CGS-20625 wikiPageWikiLink Category:Anxiolytics.
- CGS-20625 wikiPageWikiLink Category:GABAA_receptor_positive_allosteric_modulators.
- CGS-20625 wikiPageWikiLink Category:Lactams.
- CGS-20625 wikiPageWikiLink Category:O-Methylated_phenols.
- CGS-20625 wikiPageWikiLink Nonbenzodiazepine.
- CGS-20625 wikiPageWikiLinkText "CGS-20625".
- CGS-20625 atcPrefix "none".
- CGS-20625 bioavailability "41.0".
- CGS-20625 c "18".
- CGS-20625 casNumber "111205".
- CGS-20625 chemspiderid "143700".
- CGS-20625 h "19".
- CGS-20625 hasPhotoCollection CGS-20625.
- CGS-20625 inchi "1".
- CGS-20625 inchikey "UBLXQFIFWUEVGJ-UHFFFAOYAO".
- CGS-20625 iupacName "5678910".
- CGS-20625 molecularWeight "309.36236".
- CGS-20625 n "3".
- CGS-20625 o "2".
- CGS-20625 pubchem "163844".
- CGS-20625 routesOfAdministration "oral".
- CGS-20625 smiles "COC1=CC=CN2CC3=CN=C4CCCCCC4=C3N2".
- CGS-20625 stdinchi "1".
- CGS-20625 stdinchikey "UBLXQFIFWUEVGJ-UHFFFAOYSA-N".
- CGS-20625 verifiedfields "changed".
- CGS-20625 verifiedrevid "424691650".
- CGS-20625 watchedfields "changed".
- CGS-20625 width "180".
- CGS-20625 wikiPageUsesTemplate Template:Anxiolytics.
- CGS-20625 wikiPageUsesTemplate Template:Drugbox.
- CGS-20625 wikiPageUsesTemplate Template:GABAAR_PAMs.
- CGS-20625 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- CGS-20625 wikiPageUsesTemplate Template:Reflist.
- CGS-20625 subject Category:Anxiolytics.
- CGS-20625 subject Category:GABAA_receptor_positive_allosteric_modulators.
- CGS-20625 subject Category:Lactams.
- CGS-20625 subject Category:O-Methylated_phenols.
- CGS-20625 hypernym Drug.
- CGS-20625 type Article.
- CGS-20625 type ChemicalSubstance.
- CGS-20625 type Drug.
- CGS-20625 type Amide.
- CGS-20625 type Article.
- CGS-20625 type Chemical.
- CGS-20625 type Drug.
- CGS-20625 type Ether.
- CGS-20625 type Heterocycle.
- CGS-20625 type Lactam.
- CGS-20625 type ChemicalObject.
- CGS-20625 type Thing.
- CGS-20625 type Q8386.
- CGS-20625 comment "CGS-20625 is an anxiolytic drug used in scientific research. It has similar effects to, and binds to the same target as benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.CGS-20625 produces anxiolytic and anticonvulsant effects, but with no sedative effects even at high doses, and no significant muscle relaxant effects. It is orally active in humans, but with relatively low bioavailability.".
- CGS-20625 label "CGS-20625".
- CGS-20625 sameAs m.03wcd_7.
- CGS-20625 sameAs CGS-20625.
- CGS-20625 sameAs CGS-20625.
- CGS-20625 sameAs Q5010987.
- CGS-20625 sameAs Q5010987.
- CGS-20625 wasDerivedFrom CGS-20625?oldid=659857158.
- CGS-20625 depiction CGS-20625.svg.
- CGS-20625 isPrimaryTopicOf CGS-20625.